Literature DB >> 2689012

Clinical pharmacokinetics of terbinafine (Lamisil).

J C Jensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2689012     DOI： 10.1111/j.1365-2230.1989.tb00904.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  18 in total

Review 1.  Pharmacokinetics of newer drugs in patients with renal impairment (Part I).

Authors:  J P Fillastre; E Singlas
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

2.  Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds.

Authors:  Marija Tubic-Grozdanis; Michael B Bolger; Peter Langguth
Journal:  AAPS J       Date:  2008-04-02       Impact factor: 4.009

3.  Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption.

Authors:  K Balon; B U Riebesehl; B W Müller
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

Review 4.  Terbinafine. An update of its use in superficial mycoses.

Authors:  K J McClellan; L R Wiseman; A Markham
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

5.  Correlation of In Vitro Susceptibility Based on MICs and Squalene Epoxidase Mutations with Clinical Response to Terbinafine in Patients with Tinea Corporis/Cruris.

Authors:  Ananta Khurana; Aradhana Masih; Anuradha Chowdhary; Kabir Sardana; Sagar Borker; Aastha Gupta; R K Gautam; P K Sharma; Dhruv Jain
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

6.  Lamisil (terbinafine) toxicity: Determining pathways to bioactivation through computational and experimental approaches.

Authors:  Dustyn A Barnette; Mary A Davis; Na L Dang; Anirudh S Pidugu; Tyler Hughes; S Joshua Swamidass; Gunnar Boysen; Grover P Miller
Journal:  Biochem Pharmacol       Date:  2018-08-02       Impact factor: 5.858

7.  Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease.

Authors:  R A Maldonado; J Molina; G Payares; J A Urbina
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

8.  Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis.

Authors:  Daoud Al-Badriyeh; Chin Fen Neoh; Kay Stewart; David C M Kong
Journal:  Clin Ophthalmol       Date:  2010-05-06

Review 9.  Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses.

Authors:  J A Balfour; D Faulds
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

10.  Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites.

Authors:  J M Kovarik; E A Mueller; H Zehender; J Denouël; H Caplain; L Millerioux
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.